Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) - Total Liabilities

Latest as of March 2026: CN¥1.42 Billion CNY ≈ $207.52 Million USD

Based on the latest financial reports, Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) has total liabilities worth CN¥1.42 Billion CNY (≈ $207.52 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688179 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Shanghai Aladdin Biochemical Technology Co. Ltd. A - Total Liabilities Trend (2019–2025)

This chart illustrates how Shanghai Aladdin Biochemical Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Shanghai Aladdin Biochemical Technology balance sheet assets.

Shanghai Aladdin Biochemical Technology Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Shanghai Aladdin Biochemical Technology Co. Ltd. A ranked by their total liabilities.

Company Country Total Liabilities
Dis-Chem Pharmacies
JSE:DCP
South Africa ZAC13.72 Billion
Hefei Urban Construction Development Co Ltd
SHE:002208
China CN¥22.82 Billion
Kuangda Technology Group Co Ltd
SHE:002516
China CN¥771.37 Million
McEwen Mining Inc.
TO:MUX
Canada CA$319.81 Million
Delta Galil Industries Ltd
TA:DELT
Israel ILA1.18 Billion
Taiji Computer Corp Ltd
SHE:002368
China CN¥10.85 Billion
Ls Cable & System Asia Ltd
KO:229640
Korea ₩308.12 Billion
Jingsu Jingshen Salt&Chem
SHG:603299
China CN¥5.26 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Shanghai Aladdin Biochemical Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Shanghai Aladdin Biochemical Technology to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.44 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.54 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Aladdin Biochemical Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Aladdin Biochemical Technology Co. Ltd. A (2019–2025)

The table below shows the annual total liabilities of Shanghai Aladdin Biochemical Technology Co. Ltd. A from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥1.49 Billion
≈ $218.51 Million
+135.07%
2024-12-31 CN¥635.25 Million
≈ $92.96 Million
+35.40%
2023-12-31 CN¥469.15 Million
≈ $68.65 Million
-6.92%
2022-12-31 CN¥504.03 Million
≈ $73.75 Million
+583.09%
2021-12-31 CN¥73.79 Million
≈ $10.80 Million
+57.50%
2020-12-31 CN¥46.85 Million
≈ $6.86 Million
+5.49%
2019-12-31 CN¥44.41 Million
≈ $6.50 Million
--

About Shanghai Aladdin Biochemical Technology Co. Ltd. A

SHG:688179 China Chemicals
Market Cap
$1.22 Billion
CN¥8.36 Billion CNY
Market Cap Rank
#8109 Global
#1881 in China
Share Price
CN¥23.10
Change (1 day)
+2.21%
52-Week Range
CN¥11.99 - CN¥30.21
All Time High
CN¥52.53
About

Shanghai Aladdin Biochemical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of scientific research reagents in China and internationally. It offers chemistry and biochemicals reagents, including blocks, ligands, catalysts, chemical synthesis, laboratory chemicals, chemical biology, analytical standards, CVD and ALD precursors, and s… Read more